Journal ArticleDOI
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
Ajay K. Kakkar,Benjamin Brenner,Ola E. Dahl,Bengt I. Eriksson,Patrick Mouret,James Muntz,Andrea G. Soglian,Akos F. Pap,Frank Misselwitz,Sylvia Haas +9 more
Reads0
Chats0
TLDR
Extended thromboprophylaxis with rivaroxaban was significantly more effective than short-term enoxaparin plus placebo for the prevention of venous thromboembolism, including symptomatic events, in patients undergoing total hip arthroplasty.About:
This article is published in The Lancet.The article was published on 2008-07-05. It has received 1065 citations till now. The article focuses on the topics: Rivaroxaban & Enoxaparin sodium.read more
Citations
More filters
Journal ArticleDOI
Prevention of VTE in Nonsurgical Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Yngve Falck-Ytter,Charles W. Francis,Norman A. Johanson,Catherine Curley,Ola E. Dahl,Sam Schulman,Thomas L. Ortel,Stephen G. Pauker,Clifford W. Colwell +8 more
TL;DR: In this article, the authors focus on optimal prophylaxis to reduce postoperative pulmonary embolism and DVT following major orthopedic surgery, and suggest the use of low-molecular-weight heparin in preference to the other agents we have recommended as alternatives.
Journal ArticleDOI
Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017
Sandra I. Berríos-Torres,Craig A Umscheid,Dale W. Bratzler,Brian F Leas,Erin C. Stone,Rachel R. Kelz,Caroline E. Reinke,Sherry Morgan,Joseph S. Solomkin,John E. Mazuski,E. Patchen Dellinger,Kamal M.F. Itani,Elie F. Berbari,John Segreti,Javad Parvizi,Joan C. Blanchard,George Allen,Jan Kluytmans,Rodney M. Donlan,William P. Schecter +19 more
TL;DR: This guideline is intended to provide new and updated evidence-based recommendations for the prevention of SSI and should be incorporated into comprehensive surgical quality improvement programs to improve patient safety.
Journal ArticleDOI
Prevention of VTE in Orthopedic Surgery Patients
Yngve Falck-Ytter,Charles W. Francis,Norman A. Johanson,Catherine Curley,Ola E. Dahl,Sam Schulman,Thomas L. Ortel,Stephen G. Pauker,Clifford W. Colwell +8 more
TL;DR: Optimal strategies for thromboprophylaxis after major orthopedic surgery include pharmacologic and mechanical approaches.
Journal ArticleDOI
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Jessica L. Mega,Eugene Braunwald,Stephen D. Wiviott,Jean-Pierre Bassand,Deepak L. Bhatt,Christoph Bode,Paul Burton,Marc Cohen,Nancy Cook-Bruns,Shinya Goto,Sabina A. Murphy,Alexei N. Plotnikov,David J. Schneider,Xiang Sun,C. Michael Gibson +14 more
TL;DR: In patients with a recent acute coronary syndrome, rivaroxaban reduced the risk of the composite end point of death from cardiovascular causes, myocardial infarction, or stroke in a double-blind, placebo-controlled trial.
Journal ArticleDOI
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
Jan Steffel,Peter Verhamme,Tatjana S. Potpara,Pierre Albaladejo,M Antz,Lien Desteghe,Karl Georg Haeusler,Jonas Oldgren,Holger Reinecke,Roldan-Schilling,Nigel Rowell,Peter Sinnaeve,Ronan Collins,Alan John Camm,Hein Heidbuchel +14 more
TL;DR: Non-vitamin K antagonist oral anticoagulants (NOACs) are an alternative for vitamin K antagonists (VKAs) to prevent stroke in patients with atrial fibrillation (AF) and have emerged as the preferred choice, particularly in patients newly started on antICOagulation.
References
More filters
Journal ArticleDOI
Prevention of venous thromboembolism
Willitim Geerts,Joel C. Ray,Clifford W. Colwell,David Bergqvist,Graham F. Pineo,M. R. Lassen,John A. Heit +6 more
TL;DR: The risk factors for VTE among hospitalized patients are outlined, the efficacy and safety of alternative prophylaxis regimens are reviewed, and recommendations regarding the most suitable prophymic regimens based on the estimated risk are provided.
Journal ArticleDOI
Prevention of Venous Thromboembolism : The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
William H. Geerts,Graham F. Pineo,John A. Heit,David Bergqvist,Michael R. Lassen,Clifford W. Colwell,Joel G. Ray +6 more
TL;DR: This article discusses the prevention of venous thromboembolism (VTE) and is part of the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines.
Making health care safer: a critical analysis of patient safety practices.
TL;DR: This project aimed to collect and critically review the existing evidence on practices relevant to improving patient safety and identify practices with the strongest supporting evidence that decrease the risks associated with hospitalization, critical care, or surgery.
Journal ArticleDOI
Prevention of venous thromboembolism.
TL;DR: Estimates of risk and a summary of effective prophylaxis methods are provided such that physicians can tailor an individual patient's proPHylaxis regimen to maximize DVT risk reduction in the safest and most cost-effective manner.
Journal ArticleDOI
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial
Jeremy L. O'Brien,H Duncan,George Kirsh,V Allen,P King,R Hargraves,L. Mendes,T Perera,P Catto,Steven R. Schofield,H Ploschke,T Hefner,M Churchland,S Woolnough,R Wuttke,Maurice Manning,T Jeffries,L Hensley,Philip M.W. Bath,D Bainbridge,F Guinane,L McMahon,D Zavattaro,David Wilson,K Blake,J Morton,D Sharman,R Locke,J Ghabrial,S McNeil,P Rehfisch,S van der Merwe,B Einoder,D. Douglas,J Ashwell,A Morrissey,Alex Brown,R Simm,G Fisch,W Crawford,T Everding,D Tanham,J Hooper,C Aldana,M Goldwasser,M Mibus,Neville Rowden,J Mills,P Johnson,J Stilwell,Richard S. Williams,T Stevenson,J Zwar,R Bauze,B Nyunt,R Russell,G Day,M Cameron,P Clements,Thomas J. Beck,A Ellis,S Phipps,W Quaill,A Skirving,M McGuiness,P Gray,J Rankin,David A. Wood,J.,B Courtenay,Martin S. Green,Ian A. Harris,J Rush,M Kilgour,J Davies,J Newcombe,C Lewis,S Leitl,R Chilcott,R Pianta,A Aguila,C Hawe,S Nade,Mari Smith,P Robertson,A Rothwell,S May,Steven Williams,S Shamy,G Martin,V Steele,Kathryn J. Jeffery,I Kelman,J McKillan,P Dayaram,J Culling,D Lawson,P Winfield,R Kuzel,C Milburn,N Palmer,A Pitts,G Lamb,L Prodan,Harley Gray,K Walker,Kenneth Smith,Charles R. Newton,D Atkinson,B Fail,A Panting,J Menzies,A Watkiss,J Outhred,D Clay,R Lander,R Fou,D S Clarke,T Murrell,B Rolleston,S Keyworth,P Medlicott,T Woods,C Dawe,R Waldron,W Taine,L Le Roy,Andrew Smith,G Cowley,Colin A. Campbell,R Maxwell,M Elvy,Allen Thurston,S Newth,L Cousins,M Sanderson,C MacMillan,R Golele,J Walters,S Kruger,T Ramsden,H Joseph,D Gantz,S Steyn,S Hadjichristofis,L Nojoko,R Snowdowne,M Botha,R Knebel,I Sernbo,B Ferris,E Tello,A Nevelos,C Dunn,D Warwick,J Sudhakar,J D Tuite,Jobbin Francis,M E Wallace,A Jordan,P Baird,W Fowler,Ainscow Dap.,A Harrison,A Butler-Manuel,G Broome,P Swailes,T J Stahl,A M Randall,A J Forester,J Hucker,J Redden,L Logan,P W Howard,D Brownlee,P Angus,A Boyce,B B Porter,M Arbid,J Youll,A S Ogden,C MacDowell,M Beverly,P Ramdeholl,I Nelson,I Howlett,A Weeber,A Peacock,Hubbard Mjs.,M Flanagan,C Crawshaw,A Kinninmonth,T. Campbell,S Tibrewal,Lennox Cme.,I Clifford,N Gillham,M Hunt,C Bulstrode,R Handley,Vishwanath R. Iyer,J Lawton,J Robbins,W M Harper,J Davison,P Hope,K Smallbones,W. C. Jones,K R Ratnam,J Upton,P Hirst,S Knox,T Sadique,Mohammad Saud Khan,M Umar,Joshua T. Anderson,J Frank,Peter J. Briggs,P Sanderson,D McBride,K Leese,N C Bayliss,M El-Deen,H Banan,Michael Parker,H Minhas,A Best,C Blakeway,T Salter,M A Foy,A Pollitt,Blayney Jdm.,Stephen M. Davis,E Parnell,C Ko,M L Grover,S Howells,David J. Williams,C Saunders,I Brenkel,G Mani,M Grizzle,A Henderson,T Board,C J Chadwick,M Overton,S Hodkinson,D A Macdonald,V Lewis,McDonald Rjm.,J Adamson,J Bradley,E Hodgson,J L Plewes,D Clarke,M Hullin,Jason M. Smith,G J Lemon,K Greatrex,C Miles,G Bannister,J Dare,D G Carden,J Aughton,A Stirrat,J Fishburn,A O Ebizie,M Mason,G Irvine,T Facey,C Spratt,N Kanagavel,T Gerrard,N Reissis,P Tzanetos,M Stefanotti,M Greiss,V Wright,A Rahmaty,John Archer,A Bedford,David Taylor,M Griffith,Jennifer R Evans,K Heron,B Livingstone,K O'Dwyer,David J. Wheatley,P Campbell,P Dixon,L McSweeney,Shanahan Mdg.,I Griffith,Stephen MacMahon,Anthony Rodgers,Rory Collins,C Prentice,Robyn Norton,P Ockleford,M Rutland,J Dickinson,P Gregg,D Macdonald,Mollan Rab.,J. Douglas,D Beaumont,Joanna Broad,Taane G. Clark,M. A. Henderson,A McCulloch,Bruce Neal,Rajendra Prasad,Natalie Walker,M Wood,A Beighton,P Bell,Barbara Farrell,K Murch,Norman Sharpe,Gary Gordon,Robert N. Doughty,Yogini Ratnasabapathy,John Danesh,Peter Sleight,Richard Peto,John Simes,Anthony C Keech,Tri Pep. +327 more
TL;DR: In this article, a meta-analysis of their results indicated reductions in the risks of deep-vein thrombosis and of pulmonary embolism in various high-risk groups.
Related Papers (5)
Oral rivaroxaban for symptomatic venous thromboembolism
Rupert Bauersachs,Scott D. Berkowitz,Benjamin Brenner,Harry R. Buller,Hervé Decousus,Alexander Gallus,Anthonie W. A. Lensing,Frank Misselwitz,Martin H. Prins,Gary E. Raskob,Annelise Segers,Peter Verhamme,Phil Wells,Giancarlo Agnelli,Henri Bounameaux,Alexander T. Cohen,Bruce L. Davidson,Franco Piovella,Sebastian Schellong +18 more